Comparison of bipyridyl, maltol and kojic acid action as organic vanadium ligands on activity of galactosyltransferase (EC 2.4.1.38), some physiological parameters and ultrastructure of Golgi complexes in rat hepatocytes

Folia Histochemica et Cytobiologica

Volumn 45, Issue 3, 2007, Pages 239-244

  Dabros, Wojciech ^a   Kordowiak, Anna M ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Bipyridyl; Golgi complex; Kojic acid; Maltol; Pathomorphology

Indexed keywords

BIOLOGICAL MARKER; BIPYRIDINE; GALACTOSYLTRANSFERASE; GLUCOSE; KOJIC ACID; LIGAND; MALTOL; SODIUM CHLORIDE; VANADIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; GOLGI COMPLEX; LIVER CELL; LIVER MITOCHONDRION; NONHUMAN; RAT; ULTRASTRUCTURE; WEIGHT REDUCTION;

ANIMALIA; RATTUS;

EID: 35548979911     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kordowiak A, Turyna B, Kaczmarski F, Sarnecka-Keller M. Comparison of rat plasma glycoprotein composition with biochemical activity and morphology of liver Golgi apparatus in streptozotocin-diabetes treated with insulin. Folia Histochem Cytochem. 1981;19:179-186.
2. Samecka-Keller M, Kaczmarski F, Kordowiak A (1980) Morphology of the Golgi apparatus in streptozotocin-diabetic rat liver. Path Res Pract. 1980;168:126-133.
3. Sarnecka-Keller M, Kordowiak A The activity of Golgi membrane galactosyl transferase EC 2.4.1.38.in the livers of streptozotocin diabetic rats. Acta Biochim Polon. 1977;24:179-185.
4. Kordowiak AM, Tomecki J, Procyk K, Kapusta P. ProstaglandinE2 (dmPGE2) action in vitro on the activity of rat liver Golgi apparatus galactosyltransterase. Acta Biochim Polon. 1993;40:1-5.
5. Kordowiak AM. Cytoprotective effect of 16,16′ dimethyl-prostaglandin E2 (dm PGE2) on streptozotocin-induced alterations of Golgi-rich membrane fraction in comparison with morphology of rat liver Golgi apparatus in situ. Path Res Pract. 1986;181:397-402.
6. Dabroś W, Dziga D, Gryboś R, Kordowiak AM. Biochemical and morphological alterations in rat liver Golgi complexes after treatment with bis(maltolato)-oxovanadium(IV) [BMOV] or maltol alone. Path Res Pract. 2000;196:561-568.
7. 2O. Part II. Prolonged treatment with vanadium compound. Pol J Pathol. 2000;51:17-24.
8. Kordowiak AM, Dudek B, Gryboś R Influence of sodium bis(oxalato)-oxovanadate(IV) on phospholipids in liver Golgi fractions from control and streptozotocin-diabetic rats. Comp Biochem Physiol part C. 2000;125:11-16.
9. Kordowiak AM, Trzos R, Gryboś R. Insulin-like effects on liver Golgi membrane preparations of bis(oxalato)oxovanadate(IV) complex ion, a new vanadate compound. Horm Metab Res. 1997;29:104-108.
10. Kordowiak AM, Dziga D, Dabroś W. Streptozotocin-induced alterations of rat liver Golgi complexes are ameliorated by BMOV [bis(maltolato)oxovanadium(IV)] activity. Horm Metab Res 2004;36:148-154.
11. Dabroś W, Nikiforuk A, Kordowiak AM. Alterations of morphology and biochemical activity of rat liver Golgi complexes induced by pretreatment with bis(kojato)-oxovanadium(IV) or after kojic acid alone. Pol J Pathol. 2004;55:15-21.
12. Dabroś W, Kajda B, Kordowiak AM. Control and STZ-diabetic rat liver Golgi complexes under the influence of bis(2,2′-bipyridine)oxovanadium(IV) sulphate. The morphological investigation. Pol J Pathol. 2002;53:59-65.
13. Kordowiak AM, Dabroś W, Kajda B. The influence of a new vanadium compound, bis(2,2′-bipyridine)oxovanadium(IV) sulphate on liver Golgi complexes from control and streptozotocin-diabetic rats. Horm Metab Res. 2002;34:1-5.
14. Willsky GR, Goldfine AB, Kostyniak PJ, McNeill JC, Yang LQ, Khan HR, Crans DC Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulphate and bis(maltolato)oxovanadium(IV). J Inorg Biochem. 2001;85:33-42.
15. Yuen VG, Caravan P, Gelmini L, Glover N, McNeill JH, Setyawati IA, Zhou R, Orvig C. Glucose lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands. J Inorg Biochem. 1997;68:109-116.
16. Fleischer B Isolation and characterization of Golgi apparatus and membranes from rat liver. In: Fleischer S, Packer L. ed. Methods in Enzymology. Acad Press Inc, New York 1974: 31A:180-191.
17. Somogyi MJ, Nelson N. Determination of reducing sugars and carbohydrates In: Whistler R, Wolprom M. ed. Methods in Carbohydrate Chemistry. Acad Press, New York, London 1962;1:380-394.
18. Lowry OH, Resebrough NJ, Farr AL., Randall RJ Protein measurement with Folin phenol reagent. J Biol Chem. 1951;193:265-275.
19. Karnovsky MJ A. formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. J Cell Biol. 1965;27:137A-138A.
20. Venable JH, Coggeshall RA. Simplified led citrate stain use in electron microscopy. J Cell Biol. 1965;25:407-408.
21. 4] on biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes. Pol J Pathol. 2004;55:25-32.
22. Kordowiak AM, Goc A, Drozdowska E, Turyna B, Dabroś W. Sodium orthovanadate exerts influence on liver Golgi complexes from control and STZ-diabetic rats. J Inorg Biochem. 2005;99:1083-1089.
23. Mukherjee B, Patra B, Mahapatra S, Banerjee P, Tiwari A, Chatterjee M. Vanadium-an element of atypical biological significance. Toxicol Lett. 2004; 150: 135-143
24. Crans DC, Smee JJ, Gaidamauskas E, Yang L. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem Rev. 2004;104:849-902.
25. Rodriguez-Mercado JJ, Roldan-Reyes E, Altamirano-Lozano M. Genotoxic effects of vanadium(IV) in human peripheral blood cells. Toxicol. Lett 2003;144:359-369.
26. Yang XG, Yang XD, Yuan L, Wang K, Crans DC. The permeability and cytotoxicity of insulin-mimetic vanadium compounds. Pharmacol Res. 2004;21:1026-1033.
27. Thompson KH, Orvig C. Vanadium in diabetes: 100 years from phase 0 to phase 1. J Inorg Biochem. 2006;100:1925-1935.
28. Thompson KH, Tsakuda Y, Xu Z, Bartel M, McNeill JH, Orvig C. Influence of chelation and oxidation state of vanadium bioavailability and their effects on tissue concentrations of zinc, cooper and iron. Biological Trace Element Research. 2002;86:31-44 Humana Press Inc
29. Woo LCY, Yuen VG, Thompson KH, McNeill JH, Orvig C. Vanadyl-biquanide complexes as potential synergistic insulin mimics. J Inorg Biochem. 1999;76:251-257.
30. Kiersztan A, Winiarska K, Drozak J, Przedlacka M, Wegrzynowicz M, Fraczyk T, Bryla J. Differential effects of vanadium, tungsten and molybdenum on inhibition of glucose formation in renal tubules and hepatocytes of control and diabetic rabbits: beneficial action of melatonin and N-acetylcysteine. Mol Cell Biochem. 2004;261:9-21.
31. Thompson KH, Chiles J, Yuen VG, Tse J, McNeill JH, Orvig C. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes. J Inorg Biochem. 2004;98:683-690.